Beta Drugs Ltd

NSE: BETA · BSE: 531481 · Pharmaceuticals & Biotechnology · 27 announcements

Share price: ₹1,981.10
Market cap: ₹2,196 Cr
Revenue (annual): ₹384.8 Cr
Net profit (annual): ₹41.48 Cr
P/E (TTM): 48.2×Sector 47.4×
Promoter holding: 59.10%-5.53% QoQ
FII holding: 1.02%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

7 Apr 2026 15:15 IST NSE

Beta Drugs Share Pledge

Beta Drugs Limited promoters, including Rahul Batra and Varun Batra, have disclosed a nil-pledge status for the period ending March 31, 2026. The filing confirms that no shares held by the promoter group are encumbered or pledged, reflecting strong promoter ownership stability.

Read the filing ↗